EE432 Cost-Effectiveness Analysis of Sacubitril/Valsartan in Implantable Cardioverter-Defibrillator Eligible Patients
Jul 1, 2022, 00:00 AM
10.1016/j.jval.2022.04.680
https://www.valueinhealthjournal.com/article/S1098-3015(22)00881-6/fulltext
Section Title :
Section Order :
10611
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00881-6&doi=10.1016/j.jval.2022.04.680